Cargando…
ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair
Tumor cells frequently evolved resistance to cisplatin that greatly compromises the efficacy of chemotherapy. Identification of the mechanisms underlying drug resistance is important for developing new therapeutic approaches. ISG15 is found to be elevated in many human carcinomas and cancer cell lin...
Autores principales: | Huo, Yi, Zong, Zhaoyun, Wang, Qingtao, Zhang, Zhenyu, Deng, Haiteng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746079/ https://www.ncbi.nlm.nih.gov/pubmed/29296177 http://dx.doi.org/10.18632/oncotarget.22488 |
Ejemplares similares
-
ISG15 fast-tracks DNA replication
por: Meroni, Alice, et al.
Publicado: (2020) -
Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification
por: Park, Jong Ho, et al.
Publicado: (2016) -
ISG15: It's Complicated
por: Dzimianski, John V., et al.
Publicado: (2019) -
Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
por: Huo, Yi, et al.
Publicado: (2016) -
p53 vs. ISG15: Stop, you’re killing me
por: Menendez, Daniel, et al.
Publicado: (2014)